InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	9.33	11.08	6.57	8.91	6.18	7.36
Short-Term Investments	0.04	0.04	0.04	0.04	0.04	0.05
Cash & Short-Term Investments	9.37	11.12	6.61	8.96	6.22	7.41
Cash Growth	66.61%	68.10%	-26.15%	43.96%	-16.03%	26.70%
Accounts Receivable	0.34	0.47	0.35	0.26	0.09	-
Other Receivables	-	-	-	-	-	0.01
Receivables	0.34	0.47	0.35	0.26	0.09	0.01
Inventory	0.89	0.96	1.24	1.62	2.49	-
Prepaid Expenses	0.19	0.32	0.48	0.5	0.8	0.84
Other Current Assets	-	-	-	-	-	0.11
Total Current Assets	10.8	12.87	8.69	11.33	9.6	8.38
Property, Plant & Equipment	0.88	0.99	1.25	0.72	0.9	0.33
Other Intangible Assets	1.58	1.62	1.78	1.95	2.11	1.06
Other Long-Term Assets	0.1	0.1	0.1	0.1	0.18	0.01
Total Assets	13.36	15.58	11.82	14.11	12.79	9.78
Accounts Payable	0.37	0.37	0.63	0.54	1.17	0.78
Accrued Expenses	0.59	1.03	0.99	1.06	1.25	1.36
Current Portion of Leases	0.42	0.44	0.32	0.38	0.4	0.08
Other Current Liabilities	0.17	0	0.04	0.02	0.5	-
Total Current Liabilities	1.55	1.84	1.97	2	3.32	2.22
Long-Term Leases	0.22	0.31	0.64	0.02	0.39	0.19
Total Liabilities	1.77	2.15	2.62	2.02	3.71	2.4
Common Stock	91.81	91.22	82.78	77.62	70.72	60.59
Additional Paid-In Capital	38.62	39.32	35.37	35.74	31.68	21.51
Retained Earnings	-118.96	-117.24	-109.08	-101.4	-93.45	-74.85
Comprehensive Income & Other	0.13	0.13	0.13	0.13	0.13	0.13
Shareholders' Equity	11.59	13.43	9.21	12.09	9.08	7.38
Total Liabilities & Equity	13.36	15.58	11.82	14.11	12.79	9.78
Total Debt	0.64	0.74	0.96	0.39	0.79	0.27
Net Cash (Debt)	8.73	10.38	5.65	8.57	5.43	7.14
Net Cash Growth	91.19%	83.62%	-34.01%	57.80%	-23.98%	29.08%
Net Cash Per Share	2.21	10.63	14.83	69.96	193.57	531.24
Filing Date Shares Outstanding	3.95	2.38	0.67	0.17	0.05	0.02
Total Common Shares Outstanding	3.95	2	0.45	0.17	0.03	0.02
Working Capital	9.24	11.03	6.72	9.33	6.28	6.16
Book Value Per Share	2.93	6.71	20.64	72.65	279.06	458.14
Tangible Book Value	10.01	11.81	7.42	10.14	6.97	6.31
Tangible Book Value Per Share	2.53	5.90	16.65	60.95	214.23	392.20
Machinery	-	0.43	0.47	0.48	0.25	0.07
Leasehold Improvements	-	-	-	-	-	0.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q